DOI:
10.1055/s-00000017
Experimental and Clinical Endocrinology & Diabetes
LinksClose Window
References
Kawanami D, Matoba K, Takeda Y. et al.
SGLT2 inhibitors as a therapeutic option for diabetic nephropathy.
Int J Mol Sci 2017;
18: 1083
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.